FDA approves High Dose Regimen of SPINRAZA for people living with SMA
SPINRAZA is an antisense oligonucleotide therapy that increases production of survival motor neuron (SMN) protein, essential for motor neuron function
SPINRAZA is an antisense oligonucleotide therapy that increases production of survival motor neuron (SMN) protein, essential for motor neuron function
The S series with full stainless-steel body is specially designed for GMP/GLP labs
The technology selectively shuts down cancer reproducing cells
Boehringer Ingelheim expands its collaboration with OpenProtein.AI following successful initial deployment, co-developing integrated workflows for next-generation therapeutic development
Genome Detective is a cloud-based bioinformatics environment that automates the identification and characterization of viral and bacterial pathogens from NGS datasets
Strategic collaboration integrates organ-on-chip technology into preclinical glioblastoma research to improve translational relevance
Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research
The cobas c 703 and cobas ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory workflows and advance patient care
Provides an automated, functionally closed approach to help address variability and support more reliable, consistent manufacturing outcomes